(R)-3-((1-甲基吡咯烷-2-基)甲基)-1H-吲哚结构式
|
常用名 | (R)-3-((1-甲基吡咯烷-2-基)甲基)-1H-吲哚 | 英文名 | (R)-3-((1-Methylpyrrolidin-2-Yl)Methyl)-1H-Indole |
|---|---|---|---|---|
| CAS号 | 143322-55-8 | 分子量 | 214.30600 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C14H18N2 | 熔点 | N/A | |
| MSDS | 美版 | 闪点 | N/A |
| 中文名 | (R)-3-((1-甲基吡咯烷-2-基)甲基)-1H-吲哚 |
|---|---|
| 英文名 | 3-{[(2R)-1-Methyl-2-pyrrolidinyl]methyl}-1H-indole |
| 英文别名 | 更多 |
| 分子式 | C14H18N2 |
|---|---|
| 分子量 | 214.30600 |
| 精确质量 | 214.14700 |
| PSA | 19.03000 |
| LogP | 2.74250 |
| 储存条件 | 室温 |
|
~96%
(R)-3-((1-甲基吡咯烷... 143322-55-8 |
| 文献：Madasu, Suri Babu; Vekariya, Nagaji Ambabhai; Hari Kiran; Gupta, Badarinadh; Islam, Aminul; Douglas, Paul S.; Babu, Korupolu Raghu Beilstein Journal of Organic Chemistry, 2012 , vol. 8, p. 1400 - 1405 |
|
~%
(R)-3-((1-甲基吡咯烷... 143322-55-8 |
| 文献：Allelix Biopharmaceuticals Inc. Patent: US6100291 A1, 2000 ; |
|
~%
(R)-3-((1-甲基吡咯烷... 143322-55-8 |
| 文献：Abate, Carmen; Kolanos, Renata; Dukat, Malgorzata; Setola, Vince; Roth, Bryan L.; Glennon, Richard A. Bioorganic and Medicinal Chemistry Letters, 2005 , vol. 15, # 15 p. 3510 - 3513 |
| (R)-3-((1-甲基吡咯烷-2-基)甲基)-1H-吲哚上游产品 2 | |
|---|---|
| (R)-3-((1-甲基吡咯烷-2-基)甲基)-1H-吲哚下游产品 0 | |
| (r)-pyrrolidin-3-ylmethyl-carbamic acid tert-butyl ester |
| (R)-3-(1-methylpyrrolidin-3-ylmethyl)-1H-indole |
| tert-butyl (3R)-pyrrolidin-3-ylmethylcarbamate |
| (R)-tert-Butyl (pyrrolidin-3-ylmethyl)carbamate |
| (R)-3-(N-methylpyrrolidin-2-ylmethyl)-1H-indole |
| (R)-1-pyrrolidin-3-ylmethylcarbamic acid tert-butyl ester |
| (R)-3-(1-methyl-2-pyrrolidinyl)methyl-1H-indole |
| (R)-3-N-Boc-aminomethyl pyrrolidine |
| (3R)-pyrrolidin-3-ylmethyl-carbamic acid tert-butyl ester |
| (3S)-pyrrolidin-3-ylmethyl-carbamic acid tert-butyl ester |
| (R)-3-(N-(tert-butyloxycarbonyl)aminomethyl)pyrrolidine |
| 3-[(R)-1-methyl-pyrrolidin-2-ylmethyl]-1H-indole |
查看所有供应商和价格请点击：
